Reports Q4 revenue $14.3M, consensus $14.2M. Tim Goodnow, president and CEO of Senseonics (SENS) said, “In 2025, we took strategic actions to set the Company up for long term growth. Successfully bringing commercial operations in-house and investing heavily in DTC marketing, we built the foundations necessary to achieve the full potential of the world’s first and only year-long CGM. We delivered encouraging commercial results last year, and expect this momentum to continue. In 2026 we plan to expand Eversense 365 compatibility with AID systems, launch in Europe and complete the Gemini pivotal trial, an important milestone for our exciting innovation pipeline. These efforts, coupled with improved margins, set Senseonics up for continued strong performance this year and beyond. We expect these efforts, coupled with improved margins, will set Senseonics up for continued strong performance this year and beyond.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SENS:
- Options Volatility and Implied Earnings Moves Today, March 02, 2026
- Options Volatility and Implied Earnings Moves This Week, March 02 – March 05, 2026
- SENS Earnings this Week: How Will it Perform?
- Senseonics, Sequel Med Tech launch twiist integrated with Eversense 365
- Senseonics announces CE Mark approval for Eversense 365 CGM system
